1. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015; 385:1460–71.

2. Choi SH, Lee SH, Khang SK, Jeon SR. IgG4-related sclerosing pachymeningitis causing spinal cord compression. Neurology. 2010; 75:1388–90.

3. Hyun JW, Kim SH, Yoo H, Hong EK, Huh SY, Kim HJ. Steroid-resistant relapsing IgG4-related pachymeningitis treated with methotrexate. JAMA Neurol. 2014; 71:222–5.

4. Kim SH, Kang Y, Oh SH, Paik S, Kim JS. Paraplegia in a patient with IgG4-related sclerosing disease: a case report. Ann Rehabil Med. 2014; 38:856–60.

5. Lee YS, Lee HW, Park KS, Park SH, Hwang JH. Immunoglobulin g4-related hypertrophic pachymeningitis with skull involvement. Brain Tumor Res Treat. 2014; 2:87–91.

6. Lee JH, Lee JY, Park DW, Ko Y, Paik SS, Lee YJ. Tumefactive immunoglobulin G4-related disease involving the dura mater: a case report and literature review. J Korean Soc Radiol. 2015; 73:108–12.

7. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 344:732–8.

8. Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012; 64:3061–7.

9. Moon SJ, Min JK. Immunoglobulin G4-related disease. J Rheum Dis. 2015; 22:213–22.

10. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012; 22:21–30.

11. Khosroshahi A, Wallace Z, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015; 67:1688–99.

12. Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol. 2014; 71:785–93.
13. Moss HE, Mejico LJ, de la Roza G, Coyne TM, Galetta SL, Liu GT. IgG4-related inflammatory pseudotumor of the central nervous system responsive to mycophenolate mofetil. J Neurol Sci. 2012; 318:31–35.

14. Liao B, Kamiya-Matsuoka C, Fang X, Smith RG. Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximab. Neurol Neuroimmunol Neuroinflamm. 2014; 1:e41.
